PHARMA-DATA S.A.
www.pharmadata.grPharma-Data SA is a private R&D and Business Development Organization established in 2000, specialized in the design and development of new pharmaceuticals products worldwide. Pharma-Data s.a. is activated in the following sectors: • Development and Optimization of new ideas for the Pharmaceutical Industry • Know-how developmet and optimization for scale-up, manufacture, quality control and release of Pharmaceutical products • Registration Dossier Preparation for the approval of the developed products • Technology Transfer between Companies • Dossier Update and improvement of the Quality, Manufacturing and Stability of old (mature) Pharmaceutical products for maintaining and/or reviving well-established therapeutics, meeting quality standards complying to the latest up-to-date guidelines and demands. Continuously seeking for new ideas, Pharma-Data s.a. was always challenged to escape from the development of classic generics. As a result Pharma-Data s.a. can present high skills of expertise in the development of hybrid formulations, added-value generics and new-fixed combination products. We are proud of our expanding customers portfolio and the outcomes of our work such as: • Average of 5-6 new developments per year • Average of 8-10 DCPs per year • More than 60 dossier updates the last 10 years • 4 valid and approved patent applications • Approximately 140 MAs worldwide
Read morePharma-Data SA is a private R&D and Business Development Organization established in 2000, specialized in the design and development of new pharmaceuticals products worldwide. Pharma-Data s.a. is activated in the following sectors: • Development and Optimization of new ideas for the Pharmaceutical Industry • Know-how developmet and optimization for scale-up, manufacture, quality control and release of Pharmaceutical products • Registration Dossier Preparation for the approval of the developed products • Technology Transfer between Companies • Dossier Update and improvement of the Quality, Manufacturing and Stability of old (mature) Pharmaceutical products for maintaining and/or reviving well-established therapeutics, meeting quality standards complying to the latest up-to-date guidelines and demands. Continuously seeking for new ideas, Pharma-Data s.a. was always challenged to escape from the development of classic generics. As a result Pharma-Data s.a. can present high skills of expertise in the development of hybrid formulations, added-value generics and new-fixed combination products. We are proud of our expanding customers portfolio and the outcomes of our work such as: • Average of 5-6 new developments per year • Average of 8-10 DCPs per year • More than 60 dossier updates the last 10 years • 4 valid and approved patent applications • Approximately 140 MAs worldwide
Read moreEmployees statistics
View all employeesPotential Decision Makers
Vice President / Formulation Dvp
Email ****** @****.comPhone (***) ****-****Chief Executive Officer
Email ****** @****.comPhone (***) ****-****Formulation Manager
Email ****** @****.comPhone (***) ****-****
Technologies
(4)